Researchers say the practice might provide a simpler and low-cost alternative to the standard treatment for obstructive sleep ...

The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...

After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

Late nights, alcohol, and smoking on weekends may be doing more than disrupting your Monday mornings. They could also be ...

I spoke with sleep experts to find the best anti-snoring pillows that will help you sleep better and improve your overall ...

Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.

In a clinic in Jaipur, a low, resonant note from a conch shell echoed through the room—and it’s all for an unlikely therapy.

Regularly blowing through a conch shell for six months significantly improved sleep among a small group of people with sleep ...

Nyxoah SA may now help make dreams come true here in the U.S. with its FDA approval for the Genio system for the treatment of ...

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...

Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ: NYXH) stock jumped 9.4% following FDA approval of its Genio system for treating moderate to severe obstructive sleep apnea (OSA).